Skip to main content
Caplight Logo









RxDiet

RxDiet

Private
New York City, New YorkHealthcare & Life Scienceshttps://www.rx-diet.com/

Last Round

Seed

Jul 23, 2024

Est. Valuation

$1.25M

Total Funding Raised

$3.96M

Momentum

Top 1%

of companies Caplight tracks

Company Overview

RxDiet is a healthcare technology company that provides an AI-driven platform for personalized nutrition, medically tailored meal plans, and fresh grocery delivery for patients with chronic conditions.

Sector

Healthcare & Life Sciences

Verticals

Patient Engagement, Healthcare Analytics, Telemedicine, Medical AI, Vertical SaaS

Business Model

B2B2C

Customer Profile

Services & Consulting, Subscription SaaS

AI Layer

Application

Keywords

food as medicinemedically tailored mealspersonalized nutritionmedically tailored nutritionhealth techchronic disease managementB2B2Cgrocery delivery integrationcare managementdigital healthdietary coachingtele-nutritionsocial determinants of healthSDOHPMPMnutrigenomics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

RxDiet Comparables

Compare RxDiet with similar companies based on industry and business-model similarity.

RxDiet comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
NourishedRx
87%
Tangelo
86%
ModifyHealth
79%

RxDiet Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJul 23, 2024
SeedAug 1, 2022
AcceleratorOct 17, 2019

Key People

Founding team and executive leadership

Roman Kalista

CEO Founder

Founding Team

Russell Brooks

Chief Operating Officer

Executive Team

RxDiet Investors

Notable investors and investment history

RxDiet investors
InvestorRounds
Better VenturesSeed
Food-XAccelerator
better venturesSeed
Blackhorn VenturesSeed
Giant VenturesSeed
SOSVSeed, Accelerator
FORM Life VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 1, 2026

    Grew 26% QoQ, from 35 to 44 employees.

  • Jul 27, 2026

    Grew 39% QoQ, from 31 to 43 employees.

RxDiet Filings

Explore SEC and related filing metadata, where available.

RxDiet filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about RxDiet's valuation, stock price, and market status.

Is RxDiet a public or private company?

RxDiet is a private company.

What is the current stock price of RxDiet?

RxDiet is a private company with no public stock price. No recent secondary market data is available.

How much is RxDiet worth (valuation)?

Valuation information for RxDiet is not publicly available.

Can I buy RxDiet stock?

RxDiet shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was RxDiet's last funding round?

RxDiet's most recent funding round was Seed on July 23, 2024.

Who are the main investors in RxDiet?

Key investors in RxDiet include Giant Ventures, SOSV.

Will RxDiet IPO soon?

No public IPO plans have been announced for RxDiet.

How can I track RxDiet secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor RxDiet's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNew York City, New York
Employee Range44
Year Founded2018
Last FundingJul 23, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?